FLGC Flora Growth: Company Short-Term Debt

Corporate emblem and logo of Flora Growth Corporation (FLGC)

The implementation of an organic agro-complex and water-saving systems optimizes costs, which impacts current debt on loans and borrowings. The 0.00 level reflects the current magnitude of liabilities. Fundamentals are supported by the development of biotech brands and a scientific approach to extraction, as well as steady demand in European B2B channels, ensuring a stable cash flow and quality of earnings for Flora Growth Corp. (FLGC).

floragrowth.ca (FLGC) - Company Short-Term Loans and Borrowings from 07/04/2022 to 01/29/2026

Summary analytical data breakdowns for Flora Growth Inc (FLGC)

- stock price and consensus target price:
Stock Price Flora Growth|FLGC - Consensus Target
- company stock capitalization data:
Market Value Flora Growth Corp.|FLGC - Total Enterprise Value
- shareholders' equity book value data:
Accounting Value per Share Flora Growth|FLGC - Accounting Value of Company|Market Capitalization to Book Value Ratio floragrowth.ca|FLGC - Total Asset Value of Company
- debt and liquidity details:
Total Debt to Capital Flora Growth Corp.|FLGC - Long-Term Debt to Capital|Short-Term Debt to Equity Flora Growth Corp.|FLGC - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Flora Growth Corp.|FLGC - Company Long-Term Liabilities|Company Short-Term Debts Flora Growth|Quick Liquidity floragrowth.ca
- earnings and valuation multiples indicators:
FLGC - Company Net Income
General company analysis:FLGC - Flora Growth
Manufactured products of Flora Growth Corp.

To assess the fundamental stability of Flora Growth Corp. (FLGC), investors must analyze the aggregate of liabilities maturing within one year. The amount of short-term financial debt reflects a balance between operational development and the risk of interest overpayments, which is critical as the company expands into European and US markets amid unstable legal regulations for cannabinoids.

Competitor analysis

Indivior - Company Short-Term Debts|Collegium Pharma (COLL) - Company Current Liabilities|Cronos (CRON) - Company Short-Term Debt|Short-Term Debt Canopy Growth Corp. (CGC)|Company Current Liabilities HITI|ACB: Company Short-Term Loans and Borrowings|Company Short-Term Debts ACHV|SKYE: Current Liabilities|Company Short-Term Debts ANEB (Anebulo)|Company Short-Term Debts InterCure Ltd INCR|NTRB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NSRX (Nasus Pharma Ltd)|igcinc.us (IGC) - Company Short-Term Debt|Company Current Liabilities MIRA Pharmaceuticals, Inc.|IMCC (IM Cannabis Corp) - Company Short-Term Debts|Adial - Current Liabilities|Company Short-Term Debt Artelo Biosciences (ARTL)|Company Short-Term Debt ENSC (ensysce.com)|Company Short-Term Debt Titan Pharmaceuticals, Inc. TTNP|Greenlane Holdings, Inc. (GNLN) - Short-Term Debt|INM - Company Short-Term Debt|Company Short-Term Loans and Borrowings AKAN (Akanda Inc)|ENVB: Company Short-Term Debts|Bright Green Corporation (BGXX) - Company Short-Term Debts|Company Current Liabilities HPCO